Tag: cipla

Cipla inks partnership with China’s Qilu Pharma for cancer biosimilar

Posted on By admin
Cipla inks partnership with China’s Qilu Pharma for cancer biosimilar

Drugmaker Cipla, through subsidiary Invagen Pharmaceuticals, has entered into a partnership with China’s Qilu Pharmaceutical for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda (pembrolizumab) in the U.S. Qilu will be responsible for development, regulatory registration and supply of the product while Cipla USA Inc. will be responsible for the commercialisation of…

Read More “Cipla inks partnership with China’s Qilu Pharma for cancer biosimilar” »

Business

Cipla receives U.S. FDA approval for generic of asthma, COPD drug

Posted on By admin
Cipla receives U.S. FDA approval for generic of asthma, COPD drug

Food and Drug Administration headquarters in White Oak, Maryland | Photo Credit: Reuters Cipla has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application (ANDA) for generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in three strengths — 100/50 mcg, 250/50 mcg, and 500/50 mcg ….

Read More “Cipla receives U.S. FDA approval for generic of asthma, COPD drug” »

Business

Cipla faces over ₹1 crore penalty by GST authority

Posted on By admin
Cipla faces over ₹1 crore penalty by GST authority

Pharma major Cipla Ltd on Friday (December 20, 2024) said a fine of over ₹1 crore has been imposed on the company by GST authority for alleged inadmissible credit claim. The company has received an order dated December 18, 2024 passed by the GST authority, imposing a penalty of ₹1,11,94,324 under applicable provisions of the…

Read More “Cipla faces over ₹1 crore penalty by GST authority” »

Business